Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
105.00    1.80 (1.74%)
Bid:
104.40
Ask:
105.00
Spread: 0.60 (0.575%)
Market Cap: £172.14m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Update

29 Dec 2008 07:00

RNS Number : 7991K
Yule Catto & Co PLC
29 December 2008
Β 

ο»Ώ

29 December 2008

Yule Catto & Co plc

Update

Yule CattoΒ & Co plc ("the Group")Β is pleased to announce that it has signed aΒ newΒ three year Β£30 million revolving loan facility with its principalΒ banks, HSBC and Barclays. This loan replaces its existing revolving bank loan facility maturing in November 2009.

During the course of this re-financing, the Board has been carefully considering the capital structure of the Group.Β Β Whilst much progress has been made on the deleveraging of the balance sheet,Β with Β£55Β millionΒ of gross proceeds received from the sale ofΒ threeΒ ofΒ ourΒ fiveΒ ImpactΒ ChemicalsΒ businesses, the balance sheet remains a core focus of the Board and itΒ aimsΒ toΒ reduce outstanding net debt to below Β£100 million over the next twelve toΒ twentyΒ four months. The Board believes this is consistent with the Group's objectives, includingΒ itsΒ financialΒ commitmentsΒ to the Group'sΒ UKΒ pension fund.

Accordingly, and in light ofΒ theΒ current financialΒ environment andΒ economicΒ uncertainty, the Board hasΒ additionallyΒ decided toΒ suspend the paymentΒ ofΒ dividendsΒ until such time as net debt is nearer to its overall target andΒ at which timeΒ the business environment and financial market conditions may well have improved. The Board anticipates reverting to the payment ofΒ a dividendΒ withinΒ twoΒ years.

AtΒ theΒ timeΒ the Group recommences the payment ofΒ a dividend, the Board anticipates rebasingΒ itΒ to aΒ levelΒ determined by comparisonΒ with its peer groupΒ andΒ whichΒ will allow an appropriate free cash flow to suit the Group's circumstances.

The Board is also pleased to confirm thatΒ for 2008Β the Group still expectsΒ to deliver underlying earnings before tax modestly ahead of last year, despiteΒ the currentΒ difficult economic conditions particularly in theΒ UKΒ and Continental Europe.

The Board believes it is too early at this time, given the prevailing economic uncertainty, to offer any firm guidance on the outturn for 2009.Β Β The Group's ImpactΒ ChemicalsΒ andΒ PharmaΒ ChemicalsΒ businesses should benefit next year from recent restructuring.Β Β Within ourΒ PolymerΒ Chemicals business we anticipate the performance of our Asian andΒ MiddleΒ EastΒ businesses to beΒ more robustΒ than that of our European businesses,Β due to local marketΒ conditions and a more resilient demand profile from our targeted markets. InΒ addition,Β theΒ currentΒ relative weakness ofΒ Sterling against the Dollar, Euro andΒ MalaysianΒ Ringgit,Β shouldΒ it continue,Β willΒ assistΒ theΒ reportedΒ Sterling earnings for a number of ourΒ businesses.

The Group continues to look at ways to improve efficiency and minimise costs. We currently have a number of initiatives in hand to do this, both withinΒ EuropeΒ and the rest of the world.Β 

These are exceptional times, with a high degree of market uncertainty and a very difficult environment for funding.Β Β Having completedΒ Β£55 million of divestments andΒ put in place a new revolving loan,Β the Board believes that,Β togetherΒ with internal actions to conserve cash and theΒ suspension of theΒ dividend, Yule Catto is now well placed to weather these conditions.

- Ends -

For further information, please contact:

Yule Catto & Co plc
Adrian Whitfield, Chief Executive
David Blackwood, Group Finance Director
Β 
01279 442791
Hogarth PartnershipΒ 
John Olsen
Andrew Jaques
Ian Payne
020 7357 9477
07770 272082

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCFKQKNNBDDFBB
Date   Source Headline
6th Nov 20084:37 pmRNSPrice Monitoring Extension
21st Oct 20086:24 pmRNSHolding(s) in Company
21st Oct 20086:24 pmRNSHolding(s) in Company
8th Sep 20084:41 pmRNSSecond Price Monitoring Extn
8th Sep 20084:36 pmRNSPrice Monitoring Extension
2nd Sep 200812:26 pmRNSHolding(s) in Company
27th Aug 20087:00 amRNSInterim Results
14th Aug 20088:59 amRNSNotice of Results
12th Aug 20087:00 amRNSSale Completion
5th Aug 20089:42 amRNSBlocklisting Interim Review
1st Aug 200812:03 pmRNSHolding(s) in Company
21st Jul 20087:00 amRNSDisposal
27th Jun 20087:00 amRNSSale Completion
26th Jun 200810:17 amRNSHolding(s) in Company
18th Jun 200811:44 amRNSHolding(s) in Company
17th Jun 200810:12 amRNSDirector/PDMR Shareholding
16th Jun 20085:14 pmRNSDirector/PDMR Shareholding
16th Jun 200810:33 amRNSDirector/PDMR Shareholding
2nd Jun 20082:57 pmRNSBlocklisting Interim Review
30th May 20082:37 pmRNSSale Completion
15th May 20084:17 pmRNSResult of AGM
15th May 20087:00 amRNSTrading Update
9th May 20081:44 pmRNSHolding(s) in Company
24th Apr 20083:00 pmRNSAnnual Information Update
14th Apr 20084:43 pmRNSAnnual Report and Accounts
8th Apr 20089:55 amRNSDirector/PDMR Shareholding
7th Apr 20084:30 pmRNSHolding(s) in Company
14th Mar 200811:48 amRNSDirector/PDMR Shareholding
14th Mar 200811:46 amRNSDirector/PDMR Shareholding
12th Mar 20087:00 amRNSFinal Results
11th Feb 20082:40 pmRNSBlocklisting Interim Review
11th Feb 20087:01 amRNSDisposal
14th Dec 20077:00 amRNSPre-close Trading Statement
30th Nov 20073:37 pmRNSBlocklisting Interim Review
28th Nov 20072:46 pmRNSHolding(s) in Company
22nd Nov 20074:25 pmRNSDirector/PDMR Shareholding
24th Sep 200710:00 amRNSGroup Finance Director
6th Sep 20077:01 amRNSInterim Results
21st Aug 20077:00 amRNSBoard Appointments
14th Aug 20079:30 amRNSHolding(s) in Company
8th Aug 200712:16 pmRNSHolding(s) in Company
1st Aug 20077:01 amRNSPlant reorganisation
24th Jul 20072:05 pmRNSHolding(s) in Company
20th Jul 20073:50 pmRNSHolding(s) in Company
13th Jul 200712:47 pmRNSHolding(s) in Company
22nd Jun 200711:16 amRNSHolding(s) in Company
1st Jun 200711:25 amRNSBlocklisting Interim Review
1st Jun 20077:01 amRNSDivisional restructuring
29th May 20072:44 pmRNSHolding(s) in Company
17th May 20074:41 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.